Virtual Event Dec. 7: CyTOF in Adoptive Cell Therapy

[cer525]

Registration is now open for a Fluidigm-sponsored virtual mini-symposium. The event features talks by experts exploring diverse aspects of CAR cell therapeutic development, from expanding our understanding of immune cell function to improving CAR T manufacturing to monitoring CAR cells in clinical research trials using mass cytometry. The presentations will be followed by a moderated panel discussion with audience Q & A.

Emerging Approaches to Improving Adoptive Cell Therapy
Tuesday, December 7, 2021

Talks begin at 07:00 PT, 10:00 ET, 15:00 GMT, 16:00 CET
Panel discussion begins at 09:00 PT, 12:00 ET, 17:00 GMT, 18:00 CET

Speakers

Greg Hopkins, PhD | Associate Manager, Scientist, 2seventy bio
Expanding CAR T cell profiling to accelerate therapeutic insights

Matthew Spitzer, PhD | Assistant Professor, UCSF
Understanding the metabolic dynamics of T cells and CAR T cells from single-cell data

Damien Roos-Weil, MD | Hematologist, Assistance Publique – Hôpitaux de Paris
Mass cytometry: A robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies

Emily Thrash, PhD | Field Application Specialist – Proteomics, Fluidigm
Introducing CyTOF XT and Maxpar Direct assays for efficient high-content immune profiling

Register here:

https://zoom.us/webinar/register/1116358003217/WN_OhHtAzYVQL2ZO9GTQ1-xvA

Clare Rogers
Marketing Director, Mass Cytometry
Fluidigm